Actavis plc (NYSE: ACT) is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| foaf:depiction | |
| assets ($) |
|
| equity ($) |
|
| founded by | |
| founding year |
|
| key person | |
| location | |
| net income ($) |
|
| number of employees |
|
| number of locations |
|
| operating income ($) |
|
| revenue ($) |
|
| thumbnail | |
| is occupation of | |
| is owner of | |
| is owning company of | |
| is parent company of |